StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
INDIAGLYCO.BO$983.40-1.10%
Fair $983.40+0.0%

INDIAGLYCO.BO

India Glycols Limited

Basic Materials / ChemicalsBSE

$983.40

-10.95 (-1.10%)

Fairly Valued+0.0%Fair Value $983.40Fund rank 25/100 · Data gapFallback financials|
SA 46/C
F-Score: 8/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 20%

FCF escenarios

weak_data · normalized FCF $-1.1B · quality 52.0/100

Data gap 25/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 20/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

46/100

C

Piotroski

8/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists.
Thesis & Journal · INDIAGLYCO.BOLocal privado en este navegador · India Glycols Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$65.9B

P/E

23.5x

↑

EV/EBITDA

11.3x

↑

ROE

10.0%

↑

Gross Margin

36.8%

↑

Debt/Equity

0.58

↑
52-Week Range$983
$794$1223

TradingView lightweight chart

INDIAGLYCO.BO price, volumen y niveles de valoración

Último $983.40Periodo +5824.1%
Fair value: $983.40

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2023–2026 · 3 años de histórico normalizado

Revenue CAGR

+17.8%

FCF CAGR

—

FCF margin

-1.3%

FCF / Net income

-0.19x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $42.11B · net income $2.93B · FCF $-543.1M

2023-FY → 2026-FY

Gross margin

36.8%+0.1% pts

Operating margin

11.7%+2.6% pts

Net margin

7.0%+2.1% pts

FCF margin

-1.3%+3.1% pts
MetricTTM
2026
2025
2024
2023
Income Statement
Revenue$42.11B$42.11B$37.68B$32.94B$25.77B
Net Income$2.93B$2.93B$2.31B$1.73B$1.25B
EBITDA$7.00B$7.00B$5.72B$4.29B$3.44B
EPS45.9545.9537.2927.9322.77
Gross Margin36.8%36.8%36.1%32.0%36.7%
Operating Margin11.7%11.7%10.5%9.7%9.1%
Net Margin7.0%7.0%6.1%5.3%4.9%
Balance Sheet
Debt/Equity0.580.580.840.660.58
Current Ratio0.830.83———
Cash Flow
Free Cash Flow$-543.1M$-543.1M$-3.98B$-1.14B$-1.13B
Returns
ROE10.0%10.0%10.2%8.4%6.6%
Valuation
P/E23.4923.4916.4215.4812.75
EV/EBITDA11.3211.329.939.328.45
P/B2.142.141.681.310.95
Growth & Yield
Revenue Growth11.8%11.8%14.4%27.8%—
EPS Growth23.2%23.2%33.5%22.7%—
Dividend Yield0.5%0.5%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

23.8%

exigente

EPS terminal req.

$87.26

Spread vs growth

-0.6%

5Y implied EPS CAGR

18.1%

exigente

EPS terminal req.

$105.59

Spread vs growth

5.1%

10Y implied EPS CAGR

14.0%

razonable

EPS terminal req.

$170.05

Spread vs growth

9.2%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +6.6%

Total return

+6.6%

Start / end P/E

24.9x → 21.4x

EPS bridge

37.29 → 45.95

Residual

-3.2%

EPS growth+23.2%
Multiple rerating-13.9%
Dividend+0.5%
Residual / FX / buybacks / cross-term-3.2%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.